The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

The US has tightened visa rules for applicants with chronic illnesses, including diabetes, heart disease, and obesity ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

The same global food system that is fueling rising obesity rates is also accelerating climate change, according to a sweeping ...

An ambitious book challenges long-held assumptions on diet and nutrition and exposes gaps in public-health guidance.

Results showed that people with obesity had blood biomarkers for Alzheimer’s that rose more rapidly, including: Tau proteins, which form toxic clumps in the brains of Alzheimer’s patients. Protein ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong connection between weight and brain disease progression.

Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

Scientists previously identified an association between soybean oil and obesity. Now, they've uncovered one of the reasons for the link.